Luskey; Kenneth L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Luskey; Kenneth L..The latest application filed is for "rapid establishment and/or termination of substantial steady-state drug delivery".

Company Profile

0.9.10

Luskey; Kenneth L. - Saratoga CA
Luskey; Kenneth L. - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery App 20130030417 - Alessi; Thomas R. ; et al.	2013-01-31
Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes Grant 8,354,448 - Luskey , et al. January 15, 2	2013-01-15
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia Grant 8,329,749 - Luskey , et al. December 11, 2	2012-12-11
Rapid establishment and/or termination of substantial steady-state drug delivery Grant 8,298,561 - Alessi , et al. October 30, 2	2012-10-30
Use of (-) (3-Trihalomethylphenoxy) (4-Halophenyl) Acetic Acid Derivatives for Treatment of Insulin Resistance, Type 2 Diabetes, Hyperlipidemia and Hyperuricemia App 20120225940 - Luskey; Kenneth L. ; et al.	2012-09-06
Rapid establishment and/or termination of substantial steady-state drug delivery App 20110076317 - Alessi; Thomas R. ; et al.	2011-03-31
Use Of (-)(3-trihalomethylphenoxy)(4-halophenyl) Acetic Acid Derivatives For Treatment Of Insulin Resistance, Type 2 Diabetes And Hyperlipidemia App 20100093853 - LUSKEY; KENNETH L. ; et al.	2010-04-15
Use Of (-) (3-trihalomethylphenoxy) (4-halophenyl) Acetic Acid Derivatives For Treatment Of Insulin Resistance, Type 2 Diabetes, Hyperlipidemia And Hyperuricemia App 20100093855 - Luskey; Kenneth L. ; et al.	2010-04-15
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Grant 7,576,131 - Luskey , et al. August 18, 2	2009-08-18
Use Of (-)(3-trihalomethylphenoxy)(4-halophenyl) Acetic Acid Derivatives For Treatment Of Insulin Resistance, Type 2 Diabetes And Hyperlipidemia App 20070270490 - Luskey; Kenneth L. ; et al.	2007-11-22
Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia App 20050075396 - Luskey, Kenneth L. ; et al.	2005-04-07
Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia App 20040039053 - Luskey, Kenneth L. ; et al.	2004-02-26
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia App 20030220399 - Luskey, Kenneth L. ; et al.	2003-11-27
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia Grant 6,646,004 - Luskey , et al. November 11, 2	2003-11-11
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Grant 6,624,194 - Luskey , et al. September 23, 2	2003-09-23
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Grant 6,613,802 - Luskey , et al. September 2, 2	2003-09-02
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia Grant 6,262,118 - Luskey , et al. July 17, 2	2001-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.